Copyright Reports & Markets. All rights reserved.

Global DNA Vaccines Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 DNA Vaccines Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global DNA Vaccines Market Size Growth Rate by Type
    • 1.4.2 Recombinant Protein Vaccine
    • 1.4.3 Gene-Based Vaccine
  • 1.3 Market by Application
    • 1.3.1 Global DNA Vaccines Market Size Growth Rate by Application
    • 1.3.2 Human
    • 1.3.3 Animal
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global DNA Vaccines Sales Estimates and Forecasts 2016-2027
  • 2.2 Global DNA Vaccines Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global DNA Vaccines Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top DNA Vaccines Regions by Sales
    • 2.4.1 Global Top DNA Vaccines Regions by Sales (2016-2021)
    • 2.4.2 Global Top DNA Vaccines Regions by Sales (2022-2027)
  • 2.5 Global Top DNA Vaccines Regions by Revenue
    • 2.5.1 Global Top DNA Vaccines Regions by Revenue (2016-2021)
    • 2.5.2 Global Top DNA Vaccines Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global DNA Vaccines Sales by Manufacturers
    • 3.1.1 Global Top DNA Vaccines Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top DNA Vaccines Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by DNA Vaccines Sales in 2020
  • 3.2 Global DNA Vaccines Revenue by Manufacturers
    • 3.2.1 Global Top DNA Vaccines Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top DNA Vaccines Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by DNA Vaccines Revenue in 2020
  • 3.3 Global DNA Vaccines Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global DNA Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global DNA Vaccines Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global DNA Vaccines Sales by Type
    • 4.1.1 Global DNA Vaccines Historical Sales by Type (2016-2021)
    • 4.1.2 Global DNA Vaccines Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global DNA Vaccines Sales Market Share by Type (2016-2027)
  • 4.2 Global DNA Vaccines Revenue by Type
    • 4.2.1 Global DNA Vaccines Historical Revenue by Type (2016-2021)
    • 4.2.2 Global DNA Vaccines Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global DNA Vaccines Revenue Market Share by Type (2016-2027)
  • 4.3 Global DNA Vaccines Price by Type
    • 4.3.1 Global DNA Vaccines Price by Type (2016-2021)
    • 4.3.2 Global DNA Vaccines Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global DNA Vaccines Sales by Application
    • 5.1.1 Global DNA Vaccines Historical Sales by Application (2016-2021)
    • 5.1.2 Global DNA Vaccines Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global DNA Vaccines Sales Market Share by Application (2016-2027)
  • 5.2 Global DNA Vaccines Revenue by Application
    • 5.2.1 Global DNA Vaccines Historical Revenue by Application (2016-2021)
    • 5.2.2 Global DNA Vaccines Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global DNA Vaccines Revenue Market Share by Application (2016-2027)
  • 5.3 Global DNA Vaccines Price by Application
    • 5.3.1 Global DNA Vaccines Price by Application (2016-2021)
    • 5.3.2 Global DNA Vaccines Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America DNA Vaccines Market Size by Type
    • 6.1.1 North America DNA Vaccines Sales by Type (2016-2027)
    • 6.1.2 North America DNA Vaccines Revenue by Type (2016-2027)
  • 6.2 North America DNA Vaccines Market Size by Application
    • 6.2.1 North America DNA Vaccines Sales by Application (2016-2027)
    • 6.2.2 North America DNA Vaccines Revenue by Application (2016-2027)
  • 6.3 North America DNA Vaccines Market Size by Country
    • 6.3.1 North America DNA Vaccines Sales by Country (2016-2027)
    • 6.3.2 North America DNA Vaccines Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe DNA Vaccines Market Size by Type
    • 7.1.1 Europe DNA Vaccines Sales by Type (2017-2027)
    • 7.1.2 Europe DNA Vaccines Revenue by Type (2017-2027)
  • 7.2 Europe DNA Vaccines Market Size by Application
    • 7.2.1 Europe DNA Vaccines Sales by Application (2017-2027)
    • 7.2.2 Europe DNA Vaccines Revenue by Application (2017-2027)
  • 7.3 Europe DNA Vaccines Market Size by Country
    • 7.3.1 Europe DNA Vaccines Sales by Country (2017-2027)
    • 7.3.2 Europe DNA Vaccines Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific DNA Vaccines Market Size by Type
    • 8.1.1 Asia Pacific DNA Vaccines Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific DNA Vaccines Revenue by Type (2018-2027)
  • 8.2 Asia Pacific DNA Vaccines Market Size by Application
    • 8.2.1 Asia Pacific DNA Vaccines Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific DNA Vaccines Revenue by Application (2018-2027)
  • 8.3 Asia Pacific DNA Vaccines Market Size by Region
    • 8.3.1 Asia Pacific DNA Vaccines Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific DNA Vaccines Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America DNA Vaccines Market Size by Type
    • 9.1.1 Latin America DNA Vaccines Sales by Type (2019-2027)
    • 9.1.2 Latin America DNA Vaccines Revenue by Type (2019-2027)
  • 9.2 Latin America DNA Vaccines Market Size by Application
    • 9.2.1 Latin America DNA Vaccines Sales by Application (2019-2027)
    • 9.2.2 Latin America DNA Vaccines Revenue by Application (2019-2027)
  • 9.3 Latin America DNA Vaccines Market Size by Country
    • 9.3.1 Latin America DNA Vaccines Sales by Country (2019-2027)
    • 9.3.2 Latin America DNA Vaccines Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa DNA Vaccines Market Size by Type
    • 6.1.1 Middle East and Africa DNA Vaccines Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa DNA Vaccines Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa DNA Vaccines Market Size by Application
    • 6.2.1 Middle East and Africa DNA Vaccines Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa DNA Vaccines Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa DNA Vaccines Market Size by Country
    • 6.3.1 Middle East and Africa DNA Vaccines Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa DNA Vaccines Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 U.A.E

11 Company Profiles

  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Overview
    • 11.1.3 Merck DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Merck DNA Vaccines Product Description
    • 11.1.5 Merck Related Developments
  • 11.2 GSK
    • 11.2.1 GSK Corporation Information
    • 11.2.2 GSK Overview
    • 11.2.3 GSK DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 GSK DNA Vaccines Product Description
    • 11.2.5 GSK Related Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Corporation Information
    • 11.3.2 Sanofi Overview
    • 11.3.3 Sanofi DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Sanofi DNA Vaccines Product Description
    • 11.3.5 Sanofi Related Developments
  • 11.4 Zoties
    • 11.4.1 Zoties Corporation Information
    • 11.4.2 Zoties Overview
    • 11.4.3 Zoties DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 Zoties DNA Vaccines Product Description
    • 11.4.5 Zoties Related Developments
  • 11.5 Elanco
    • 11.5.1 Elanco Corporation Information
    • 11.5.2 Elanco Overview
    • 11.5.3 Elanco DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 Elanco DNA Vaccines Product Description
    • 11.5.5 Elanco Related Developments
  • 11.6 Boehringer-Ingelheim
    • 11.6.1 Boehringer-Ingelheim Corporation Information
    • 11.6.2 Boehringer-Ingelheim Overview
    • 11.6.3 Boehringer-Ingelheim DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 Boehringer-Ingelheim DNA Vaccines Product Description
    • 11.6.5 Boehringer-Ingelheim Related Developments
  • 11.7 Indian Immunologicals
    • 11.7.1 Indian Immunologicals Corporation Information
    • 11.7.2 Indian Immunologicals Overview
    • 11.7.3 Indian Immunologicals DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 Indian Immunologicals DNA Vaccines Product Description
    • 11.7.5 Indian Immunologicals Related Developments
  • 11.8 Plumbline Life Sciences
    • 11.8.1 Plumbline Life Sciences Corporation Information
    • 11.8.2 Plumbline Life Sciences Overview
    • 11.8.3 Plumbline Life Sciences DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Plumbline Life Sciences DNA Vaccines Product Description
    • 11.8.5 Plumbline Life Sciences Related Developments
  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Overview
    • 11.1.3 Merck DNA Vaccines Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Merck DNA Vaccines Product Description
    • 11.1.5 Merck Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 DNA Vaccines Value Chain Analysis
  • 12.2 DNA Vaccines Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 DNA Vaccines Production Mode & Process
  • 12.4 DNA Vaccines Sales and Marketing
    • 12.4.1 DNA Vaccines Sales Channels
    • 12.4.2 DNA Vaccines Distributors
  • 12.5 DNA Vaccines Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 DNA Vaccines Industry Trends
  • 13.2 DNA Vaccines Market Drivers
  • 13.3 DNA Vaccines Market Challenges
  • 13.4 DNA Vaccines Market Restraints

14 Key Findings in The Global DNA Vaccines Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    DNA Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global DNA Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Recombinant Protein Vaccine
    Gene-Based Vaccine

    Segment by Application
    Human
    Animal

    By Company
    Merck
    GSK
    Sanofi
    Zoties
    Elanco
    Boehringer-Ingelheim
    Indian Immunologicals
    Plumbline Life Sciences

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now